Clinical studyThe effect of pulmonary fibrosis on survival in patients with hypersensitivity pneumonitis
Section snippets
Case definition
We identified 85 patients in the database of the Clinical Interstitial Lung Disease Program at the National Jewish Medical and Research Center, for the period of 1982 to 2000, who had a primary diagnosis of hypersensitivity pneumonitis and who had undergone surgical lung biopsy. Two expert lung pathologists (CDC, RMT) who were blinded to all clinical information independently reviewed the biopsy specimens. The pathologic features of a predominantly lymphoplasmocytic interstitial pneumonitis
Results
Forty-six patients were classified as having fibrotic hypersensitivity pneumonitis and 26 as nonfibrotic (Table 1). Fibrotic patients were significantly older, and a higher proportion had symptoms for more than 1 year compared with nonfibrotic subjects. Otherwise, there were no significant differences in smoking history, antigen exposure, and symptoms. Precipitin antibodies were positive in 64% of patients (n = 29) with an identified exposure, including 75% (18/24) of those exposed to a
Discussion
Our findings demonstrate that the presence of pulmonary fibrosis in patients with hypersensitivity pneumonitis is associated with significantly increased all-cause and respiratory mortality. Fibrosis was the best predictor of diminished survival of the variables tested, including symptom duration, antigen type, smoking status, and pulmonary function.
Hypersensitivity pneumonitis has generally been associated with low mortality (23). However, prior investigations have been largely limited to
References (38)
- et al.
Chronic hypersensitivity pneumonitis in Japana nationwide epidemiologic survey
J Allergy Clin Immunol
(1999) - et al.
Farmer's lungclinical, pathologic, and immunologic study of twenty-four patients
Am J Med
(1964) - et al.
Guidelines for the clin-ical evaluation of hypersensitivity pneumonitis
J Allergy Clin Immunol
(1989) - et al.
Nonspecific interstitial pneumonitis as the sole histologic expression of hypersensitivity pneumonitis
Am J Med
(2002) - et al.
Mortality due to farmer's lung in Finland
Chest
(1994) - et al.
Long-term physiologic outcome after acute farmer's lung
Chest
(1985) - et al.
Time of exposure as a prognostic factor in avian hypersensitivity pneumonitis
Respir Med
(1989) - et al.
Longitudinal pulmonary function changes in pigeon breeders
Chest
(1988) - et al.
Hypersensitivity pneumonitiscurrent concepts and future questions
J Allergy Clin Immunol
(2001) - et al.
The long-term outcome in acute, subacute, and chronic forms of pigeon breeder's disease hypersensitivity pneumonitis
Ann Allergy Asthma Immunol
(2002)
Hypersensitivity Pneumonitis
A new look at hypersensitivity pneumonitis
Curr Opin Pulm Med
Farmer's lung—a 5-year follow-up of 86 patients
Clin Allergy
Longitudinal course of extrinsic allergic alveolitis in pigeon breeders
Thorax
Farmer's lunglong-term outcome and lack of predictive value of bronchoalveolar lavage fibrosing factors
Am Rev Respir Dis
Long-term risk of emphysema in patients with farmer's lung and matched control farmers
Am J Respir Crit Care Med
The long-term prognosis in farmer's lung
Am Rev Respir Dis
Farmer's lung diseaselong-term clinical and physiologic outcome
Am Rev Respir Dis
Mortality in Mexican patients with chronic pigeon breeder's lung compared with those with usual interstitial pneumonitis
Am Rev Respir Dis
Cited by (220)
Japanese clinical practice guide 2022 for hypersensitivity pneumonitis
2024, Respiratory InvestigationClinical characteristics and outcomes of hypersensitivity pneumonitis in South Korea
2023, Therapeutic Advances in Respiratory Disease